Results 101 to 110 of about 17,282 (225)

An Unusual Complication of Foam Sclerotherapy: Acute Kidney Injury

open access: yesTurkish Journal of Nephrology, 2019
Sclerotherapy, in which an irritant solution is administered, is a method used to treat venous failure that results in complete venous destruction due to endothelial reaction and fibrosis. In recent years, foam sclerotherapy, in which a sclerosing agent (
Müge EREK   +5 more
doaj  

Airway First: A Retrospective Study of Tracheotomy-Primed Sclerotherapy for High-Risk Cervicofacial Venous Malformations

open access: yes
Objectives: This study assesses the efficacy of tracheotomy-primed sclerotherapy in craniofacial venous malformations (VMs), establishes evidence-based airway intervention criteria, and develops site-specific safety protocols to optimize treatment timing
Xuan Jiang   +5 more
core   +1 more source

Sclerotherapy of Varicose Veins with Polidocanol Based on the Guidelines of the German Society of Phlebology

open access: yes, 2010
BACKGROUND Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. OBJECTIVE To update guidelines for sclerotherapy of varicose veins.
Rabe, Eberhard   +3 more
core   +1 more source

Successful Treatment of Stomal Variceal Bleeding with Percutaneous Injection Sclerotherapy

open access: yes, 2015
Bleeding from ectopic varices is often massive and fatal with portal hypertension, and stomal varices can occur in patients with stoma. We aimed to treat a hepatitis B surface antigen positive 69 year-old male with liver cirrhosis associated ...
Takahiro Sato   +4 more
core   +1 more source

Effectiveness and side effects associated with Doxycycline as sclerotherapyin pediatric head and neck lymphangiomas

open access: yesGreenfort International Journal of Applied Medical Science
Introduction: Common side effects of doxycycline include diarrhoea, itch and skin sensitivity. Doxycycline makes your skin more sensitive, so it's extra important to protect your skin from the sun, if you are taking it.
Tawfiqur Rahman   +5 more
doaj   +1 more source

OK-432 Sclerotherapy for Malleolar Bursitis of the Ankle

open access: yes, 2013
Background: The purpose of this study was to evaluate the clinical outcomes and usefulness of OK-432 (Picibanil) sclerotherapy as a new option in the conservative treatment of patients with malleolar bursitis of the ankle.
이진우, 박광환, 최우진
core   +1 more source

Treatment of hereditary hemorrhagic telangiectasias with sclerotherapy: A case series [PDF]

open access: yes
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is characterized by abnormal blood vessel formation. One treatment for HHT-related arteriovenous malformations (AVMs) is sclerotherapy, which collapses the blood vessels by irritating the ...
Peterson, Andrew M   +2 more
core   +1 more source

Treatment of Unusual Vascular Lesions: Usefulness of Sclerotherapy in Lymphangioma Circumscriptum and Acquired Digital Arteriovenous Malformation

open access: yes, 2017
BACKGROUND: Sclerotherapy is used in venous malformations and hemangiomas, as well as chronic venous insufficiency and hemorrhoids. OBJECTIVE: To report on the usefulness of sclerotherapy in the treatment of unusual vascular lesions, such as lymphangioma
정기양
core  

Vasoactive drugs in the management of acute variceal bleeding

open access: yesThe Saudi Journal of Gastroenterology, 1997
Several methods have been used to treat acute variceal hemorrhage. Sclerotherapy is the method of choice. The use of vasoactive drugs is popular despite unsatisfactory effect and systemic hemodynamic adverse effects.
Beauchant Michel
doaj  

Novel technique of sclerotherapy for superficial lymphatic malformation

open access: yesFrontiers in Pediatrics
PurposeSuperficial lymphatic malformation (SLM), previously known as lymphangioma circumscriptum, is characterized by skin lesions that sometimes require interventional treatment. However, an effective treatment has yet to be established.
Hidehito Usui   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy